None of this changes the bottom line: no completed human clinical trial exists for any BPC-157 indication
Please note: Tracking details may take up to 24 hours to appear in the carriers system
however, this is FDA staff's proposed position going into the meeting, not a final action, and the committee's discussion, any vote, and FDA's ultimate decision are still pending, so the outcome of the review is not yet known
Split Dosing Option Some protocols call for splitting the daily dose into two administrations, typically morning and evening
Intra-Abdominal Hypertension Causes Reversible Blood-Brain Barrier Disruption
It's one of the peptides that can be administered to help with specific health concerns and promote faster recovery